NCT05867485

Brief Summary

This study aimed to evaluate the impact of specialized discharge education on the daily life activities and quality of life of geriatric patients hospitalized in COVID-19 wards. The motivation behind this study stems from the vulnerability of elderly patients during the COVID-19 pandemic and the necessity of tailored education to support their daily life activities and enhance their quality of life after discharge. The primary objective of this article is to determine the specific type of specialized discharge education that geriatric patients in COVID-19 wards require to improve their ability to sustain daily life activities and enhance their quality of life. The central idea of this study is that providing specialized discharge education to geriatric patients in COVID-19 wards can result in improvements in their daily life activities and quality of life. The main findings of the study demonstrate a significant enhancement in daily life activities and quality of life among patients who received specialized discharge education. These individuals exhibited increased independence in mobility, improved performance in daily life activities, and reported an overall improvement in their quality of life. These findings underscore the significance of specialized discharge education for geriatric patients hospitalized in COVID-19 wards and highlight its positive impact on their health outcomes and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 17, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
Last Updated

May 22, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

May 17, 2023

Last Update Submit

May 18, 2023

Conditions

Keywords

COVID-19Special Discharge TrainingGeriatricDaily Life ActivitiesQuality of Life

Outcome Measures

Primary Outcomes (4)

  • Katz Daily Life Activities Scale (GYA):

    The Katz Daily Life Activities Scale (GYA) was developed by Katz and colleagues in 1963 to assess activities essential for daily life. The scale measures the scores of key elements related to daily life activities, such as bathing, dressing, toileting, mobility, continence, and feeding. The GYA index categorizes scores as dependent (0-6 points), partially dependent (7-12 points), and independent (13-18 points). The scale has been translated into Turkish and validated by Yardımcı E., with a Cronbach's alpha coefficient of 0.73. Response options in the Katz GYA scale include "independent," "partially dependent," and "dependent."

    0 day

  • Quality of Life Scale (SF-12):

    The SF-12 Quality of Life Scale is a widely used instrument that assesses the quality of life over the past four weeks, encompassing various age and disease groups. The Turkish version of the scale, including its reliability and validity study, was conducted by Soylu and Kütük (2022). The SF-12 consists of 12 questions selected from the SF-36 Quality of Life Scale. It comprises eight sub-dimensions and 12 items, including physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role, and mental health. The SF-12 yields two summary scores: the Physical Component Summary Score (PCSS) and the Mental Component Summary Score (MCSS). The scale demonstrates a Cronbach's alpha coefficient of 0.72.

    0 day

  • Katz Daily Life Activities Scale (GYA):

    The Katz Daily Life Activities Scale (GYA) was developed by Katz and colleagues in 1963 to assess activities essential for daily life. The scale measures the scores of key elements related to daily life activities, such as bathing, dressing, toileting, mobility, continence, and feeding. The GYA index categorizes scores as dependent (0-6 points), partially dependent (7-12 points), and independent (13-18 points). The scale has been translated into Turkish and validated by Yardımcı E., with a Cronbach's alpha coefficient of 0.73. Response options in the Katz GYA scale include "independent," "partially dependent," and "dependent."

    1 month

  • Quality of Life Scale (SF-12):

    The SF-12 Quality of Life Scale is a widely used instrument that assesses the quality of life over the past four weeks, encompassing various age and disease groups. The Turkish version of the scale, including its reliability and validity study, was conducted by Soylu and Kütük (2022). The SF-12 consists of 12 questions selected from the SF-36 Quality of Life Scale. It comprises eight sub-dimensions and 12 items, including physical functioning, physical role, bodily pain, general health, vitality, social functioning, emotional role, and mental health. The SF-12 yields two summary scores: the Physical Component Summary Score (PCSS) and the Mental Component Summary Score (MCSS). The scale demonstrates a Cronbach's alpha coefficient of 0.72.

    1 month

Study Arms (2)

Control Group:

NO INTERVENTION

Initially, the Patient Diagnostic Information Form was completed. Patients were informed about the discharge process according to the regular ward procedure and were informed about their participation in the study after discharge. One month later, patients were contacted by phone, and the Daily Life Activities Scale (DLAS) and Quality of Life Scale (SF-12) forms were completed during 10-15 minute conversations.

Study Group:

EXPERIMENTAL

After obtaining informed consent from the patients, they were enrolled in the study. The COVID-19 Discharge Education Brochure, prepared by the researchers, was provided to the patients face-to-face within 10-15 minutes. One month after the discharge education, patients were contacted by phone, and the Daily Life Activities Scale (DLAS) and Quality of Life Scale (SF-12) forms were completed.

Other: COVID-19 Discharge Education

Interventions

A discharge education brochure has been developed based on information from the literature to complement the verbal information provided to patients. The content of the education brochure includes the following: 1. Information about the spread of the virus and precautions to be taken. 2. Guidelines for cleanliness and disinfection of the environment. 3. Precautions regarding personal and wearable items. 4. Information about food and beverages. 5. Guidelines for personal hygiene practices. 6. Information about quarantine and isolation. 7. Guidelines for maintaining health and care (e.g., respiratory hygiene, cough etiquette, movement, range of motion exercises) (CDC, 2019; Ministry of Health of Turkey, 2020; CDC 2019 A-B-C-D).

Also known as: education
Study Group:

Eligibility Criteria

Age65 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Islam

Kilis, 79100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

COVID-19

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • islam ELAGÖZ, PhD-c

    Kilis yesi Aralık Universty

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assıstant

Study Record Dates

First Submitted

May 17, 2023

First Posted

May 22, 2023

Study Start

April 1, 2022

Primary Completion

June 1, 2022

Study Completion

July 1, 2022

Last Updated

May 22, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations